These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23278314)

  • 1. Evolving therapeutic targets in ischemic stroke: a concise review.
    Sugunan S; Joseph DB; Rajanikant GK
    Curr Drug Targets; 2013 Apr; 14(4):497-506. PubMed ID: 23278314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolin-1 in Stroke Neuropathology and Neuroprotection: A Novel Molecular Therapeutic Target for Ischemic-Related Injury.
    Wang S; Head BP
    Curr Vasc Pharmacol; 2019; 17(1):41-49. PubMed ID: 29412114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron protection as a therapeutic target in acute ischemic stroke.
    Tuttolomondo A; Di Sciacca R; Di Raimondo D; Arnao V; Renda C; Pinto A; Licata G
    Curr Top Med Chem; 2009; 9(14):1317-34. PubMed ID: 19849659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models.
    Jhelum P; Karisetty BC; Kumar A; Chakravarty S
    Curr Neuropharmacol; 2017; 15(6):815-830. PubMed ID: 27964703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in stroke pharmacology.
    Zhou Z; Lu J; Liu WW; Manaenko A; Hou X; Mei Q; Huang JL; Tang J; Zhang JH; Yao H; Hu Q
    Pharmacol Ther; 2018 Nov; 191():23-42. PubMed ID: 29807056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cofilin as a Promising Therapeutic Target for Ischemic and Hemorrhagic Stroke.
    Alhadidi Q; Bin Sayeed MS; Shah ZA
    Transl Stroke Res; 2016 Feb; 7(1):33-41. PubMed ID: 26670926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs and cell death following ischemic stroke.
    Alishahi M; Ghaedrahmati F; Kolagar TA; Winlow W; Nikkar N; Farzaneh M; Khoshnam SE
    Metab Brain Dis; 2019 Oct; 34(5):1243-1251. PubMed ID: 31055786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis and Acute Brain Ischemia in Ischemic Stroke.
    Radak D; Katsiki N; Resanovic I; Jovanovic A; Sudar-Milovanovic E; Zafirovic S; Mousad SA; Isenovic ER
    Curr Vasc Pharmacol; 2017; 15(2):115-122. PubMed ID: 27823556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex Brain Proteomic Analysis Revealed the Molecular Therapeutic Effects of Buyang Huanwu Decoction on Cerebral Ischemic Stroke Mice.
    Chen HJ; Shen YC; Shiao YJ; Liou KT; Hsu WH; Hsieh PH; Lee CY; Chen YR; Lin YL
    PLoS One; 2015; 10(10):e0140823. PubMed ID: 26492191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic stroke and select adipose-derived and sex hormones: a review.
    Meadows KL
    Hormones (Athens); 2018 Jun; 17(2):167-182. PubMed ID: 29876798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke and Drug Delivery--In Vitro Models of the Ischemic Blood-Brain Barrier.
    Tornabene E; Brodin B
    J Pharm Sci; 2016 Feb; 105(2):398-405. PubMed ID: 26869407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in AQP Research and New Developments in Therapeutic Approaches to Ischemic and Hemorrhagic Stroke.
    Previch LE; Ma L; Wright JC; Singh S; Geng X; Ding Y
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27438832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroprotective role of the brain opioid system in stroke injury.
    Vaidya B; Sifat AE; Karamyan VT; Abbruscato TJ
    Drug Discov Today; 2018 Jul; 23(7):1385-1395. PubMed ID: 29501910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet therapy in ischemic stroke.
    Pongrácz E; Káposzta Z
    Expert Rev Neurother; 2005 Jul; 5(4):541-9. PubMed ID: 16026237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-Responsive, Brain-Targeting Nanoparticles for Improved Stroke Therapy.
    Guo X; Deng G; Liu J; Zou P; Du F; Liu F; Chen AT; Hu R; Li M; Zhang S; Tang Z; Han L; Liu J; Sheth KN; Chen Q; Gou X; Zhou J
    ACS Nano; 2018 Aug; 12(8):8723-8732. PubMed ID: 30107729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms underlying neuroprotective effects of albumin after ischemic stroke.
    Parkkinen J; Ojala P; Niiranen J; Jolkkonen J
    Stroke; 2007 Feb; 38(2):255; author reply 256. PubMed ID: 17170360
    [No Abstract]   [Full Text] [Related]  

  • 17. Ischemic stroke and glucose intolerance: a review of the evidence and exploration of novel therapeutic targets.
    Harada S; Fujita-Hamabe W; Tokuyama S
    J Pharmacol Sci; 2012; 118(1):1-13. PubMed ID: 22188858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
    Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citokines and inflammation markers in ischemic stroke.
    Tuttolomondo A
    Curr Pharm Des; 2008; 14(33):3547-8. PubMed ID: 19075731
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia.
    Miida T; Hirayama S; Nakamura Y
    J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.